News about Global Pharma

BGS US Secures ISO Certifications for New Electron Beam Sterilisation Facility

The facility will begin operations in mid-2025.

Global Pharma | 13/03/2025 | By Abha |  184

Almac Group Unveils EUR 65M Commercial Manufacturing Facility in Northern Ireland

The new 100,000sq ft facility enhances existing capabilities in commercial manufacture of oral dose treatments for a variety of therapeutic areas.

Global Pharma | 13/03/2025 | By Abha |  456

Glenmark Pharma Expands Cardiometabolic Portfolio with the Launch of Empagliflozin in India

Glenmark Pharmaceuticals has launched Empagliflozin, a widely recognised SGLT2 inhibitor under the brand Glempa, a range of Empagliflozin-based medications in India, offering advanced and affordable treatment options for type 2 diabetes mellitus with cardiovascular benefits.

Global Pharma | 12/03/2025 | By Manvi |  1327

SK bioscience Ships 750,000 Doses of SKYCellflu to Southern Hemisphere Markets

SK bioscience announced that the company has begun shipping its self-developed influenza vaccine, SKYCellflu, from its vaccine manufacturing facility L HOUSE to Southern Hemisphere markets, including Southeast Asia and Latin America.

Global Pharma | 12/03/2025 | By Manvi |  344

Exogenus Picks Lonza to Develop GMP-Compliant Process to Manufacture Exo-101

Exogenus Therapeutics specializes in the development of healthcare solutions based on extracellular vesicles, including exosomes and other nanotechnologies.

Global Pharma | 12/03/2025 | By Aishwarya |  408

OneSource Specialty Pharma Strengthens its Board with Key Independent Directors Appointment

The directors bring decades of leadership experience and expertise in Pharma, Business Strategy, Transformation, Merger & Acquisition (M&A) among others.

Global Pharma | 12/03/2025 | By Aishwarya |  561

Shilpa Medicare Gets SEC-CDSCO Nod for Nor-Ursodeoxycholic Acid Tablets

Shilpa Medicare Ltd. had earlier completed phase-3 clinical studies of this novel product SMLNUD07 – Nor Ursodeoxycholic Acid (Nor UDCA) tablets.

Global Pharma | 12/03/2025 | By Aishwarya |  727

Mahajan Imaging & Labs Hosts Roundtable Conference on Integrated Diagnostics and Women Health

The roundtable explored key issues in women’s health, including cancer screening, mental well-being, and the role of integrated diagnostics in early disease detection.

Global Pharma | 12/03/2025 | By Aishwarya |  193

Viking Therapeutics Signs Multi-Year Manufacturing Deal with CordenPharma for Obesity Drug VK2735

Under the terms of the agreement, Viking has secured dedicated capacity for the manufacture of, and a commitment to supply annually, multiple metric tons of VK2735 API.

Global Pharma | 11/03/2025 | By Manvi |  385

Endo to Sale International Pharmaceuticals Business to Knight Therapeutics for USD 99 Million

Endo, Inc. has entered into a definitive agreement to sell its international pharmaceuticals business, primarily operated through Canada-based Paladin Pharma Inc., to Knight Therapeutics Inc. for a total consideration of up to USD 99 million.

Global Pharma | 11/03/2025 | By Manvi |  203